1 study found for:    24502830 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Oral Cladribine in Early Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: Cladribine;   Drug: Placebo;   Drug: Rebif® new formulation (RNF)

Indicates status has not been verified in more than two years